Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

JNTX 104

Next Previous
Drug Profile

JNTX 104

Alternative Names: JNTX-104

Latest Information Update: 28 Jul 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator City of Hope National Medical Center; January Therapeutics
  • Class Albumins; Alcohols; Amines; Antineoplastics; Chlorinated hydrocarbons; Chlorine compounds; Purines; Ribonucleosides; Small molecules
  • Mechanism of Action Antimetabolites; RNA synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Cancer

Most Recent Events

  • 28 Jul 2024 No recent reports of development identified for research development in Cancer in USA
  • 01 Jul 2021 January Therapeutics has patents pending for nanoparticle compositions comprising organophosphate compounds and pharmaceutically acceptable carrier such as albumin in Japan, China, European Union, Australia, USA and Canada
  • 31 Aug 2020 January Therapeutics files for patent protection for nanoparticle compositions comprising organophosphate compounds and pharmaceutically acceptable carrier such as albumin in South Korea, Singapore and in Israel

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top